Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Lyell Immunopharma, Inc.
Novartis
Shanghai Jiao Tong University School of Medicine
National Cancer Institute, Egypt
Thomas Jefferson University
Baylor College of Medicine
Yale University
UNC Lineberger Comprehensive Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Genmab
St. Jude Children's Research Hospital
Gilead Sciences
The General Hospital of Western Theater Command
Affiliated Hospital to Academy of Military Medical Sciences
Baylor College of Medicine
Beijing Biotech
New Approaches to Neuroblastoma Therapy Consortium
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Gilead Sciences
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics
Medical University of Vienna
UNC Lineberger Comprehensive Cancer Center
Regeneron Pharmaceuticals
University of Leeds
Gilead Sciences
St. Jude Children's Research Hospital
Baylor College of Medicine
Celgene
Stanford University
University of Pennsylvania
Chinese PLA General Hospital
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
University of Maryland, Baltimore
Affimed GmbH
Chinese PLA General Hospital
Dana-Farber Cancer Institute
Chinese PLA General Hospital
University Health Network, Toronto
University of Pennsylvania
University of Illinois at Chicago
City of Hope Medical Center
CARGO Therapeutics
Thomas Jefferson University
City of Hope Medical Center